These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 21815699

  • 1. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.
    Croxtall JD, McKeage K.
    BioDrugs; 2011 Aug 01; 25(4):243-54. PubMed ID: 21815699
    [Abstract] [Full Text] [Related]

  • 2. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
    Tarlatzis BC, Griesinger G, Leader A, Rombauts L, Ijzerman-Boon PC, Mannaerts BM.
    Reprod Biomed Online; 2012 Apr 01; 24(4):410-9. PubMed ID: 22386594
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM, Engage Investigators.
    Reprod Biomed Online; 2010 Nov 01; 21(5):593-601. PubMed ID: 20843746
    [Abstract] [Full Text] [Related]

  • 4. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC.
    Hum Reprod; 2015 Feb 01; 30(2):432-40. PubMed ID: 25492411
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.
    Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC, ENGAGE Investigators.
    Hum Reprod; 2009 Dec 01; 24(12):3063-72. PubMed ID: 19684043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.
    Souza PMG, Carvalho BR, Nakagawa HM, Rassi TRE, Barbosa ACP, Silva AA.
    JBRA Assist Reprod; 2017 Jun 01; 21(2):67-69. PubMed ID: 28609269
    [Abstract] [Full Text] [Related]

  • 8. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2062-70. PubMed ID: 15126522
    [Abstract] [Full Text] [Related]

  • 9. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B.
    Hum Reprod; 2013 Feb 01; 28(2):442-52. PubMed ID: 23136144
    [Abstract] [Full Text] [Related]

  • 10. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.
    Corifollitropin Alfa Dose-finding Study Group.
    Hum Reprod; 2008 Nov 01; 23(11):2484-92. PubMed ID: 18684735
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome.
    Bonduelle M, Mannaerts B, Leader A, Bergh C, Passier D, Devroey P.
    Hum Reprod; 2012 Jul 01; 27(7):2177-85. PubMed ID: 22587997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.
    Fauser BC, Mannaerts BM, Devroey P, Leader A, Boime I, Baird DT.
    Hum Reprod Update; 2009 Jul 01; 15(3):309-21. PubMed ID: 19182099
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis.
    Griesinger G, Boostanfar R, Gordon K, Gates D, McCrary Sisk C, Stegmann BJ.
    Reprod Biomed Online; 2016 Jul 01; 33(1):56-60. PubMed ID: 27178762
    [Abstract] [Full Text] [Related]

  • 19. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
    Mahmoud Youssef MA, van Wely M, Aboulfoutouh I, El-Khyat W, van der Veen F, Al-Inany H.
    Fertil Steril; 2012 Apr 01; 97(4):876-85. PubMed ID: 22277766
    [Abstract] [Full Text] [Related]

  • 20. Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation.
    Loutradis D, Vlismas A, Drakakis P.
    Womens Health (Lond); 2010 Sep 01; 6(5):655-64. PubMed ID: 20887164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.